Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-20-009834
Date:2020-02-13
Issuer: ARENA PHARMACEUTICALS INC (ARNA)
Original Submission Date:

Reporting Person:

LIND KEVIN ROBERT
C/O ARENA PHARMACEUTICALS, INC.
6154 NANCY RIDGE DRIVE SAN DIEGO, CA 92121

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-02-13 M 2,500 a $19.40 5,957 direct
COMMON STOCK 2020-02-13 M 2,000 a $35.60 7,957 direct
COMMON STOCK 2020-02-13 S 4,500 d $55.00 3,457 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 19.4 2020-02-13 deemed execution date M 2,500 (d) 2023-06-15 common stock 2,500 $19.40 77,500 direct
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 35.6 2020-02-13 deemed execution date M 2,000 (d) 2025-01-19 common stock 2,000 $35.60 128,000 direct
Footnotes
IDfootnote
f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan established by the reporting person.
f2 the options vest over four years, with 25% of the shares subject to the option vesting on june 15, 2017, and the remainder of the shares vesting monthly over the following three years in equal installments (except as otherwise necessary to avoid vesting of a fractional share), and are exercisable once vested.
f3 the options vest over four years, with 25% of the shares subject to the option vesting on january 19, 2019, and the remainder of the shares vesting monthly over the following three years in equal installments (except as otherwise necessary to avoid vesting of a fractional share), and are exercisable once vested.
WhaleWisdom Logo

Elevate your investments